Bumetanide and Tumor - a phase IV clinical study of FDA data

Summary:

Tumor is reported as a side effect among people who take Bumetanide (bumetanide), especially for people who are female, 60+ old, also take Coumadin, and have Pain.

The phase IV clinical study analyzes which people have Tumor when taking Bumetanide. It is created by eHealthMe based on reports of 20,353 people who have side effects when taking Bumetanide from the FDA, and is updated regularly.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 20,532 Bumetanide users. Check the latest studies of Bumetanide.

What is Tumor?

Tumor is found to be associated with 1,419 drugs and 1,704 conditions by eHealthMe. Check the latest studies of Tumor.

On Jul, 20, 2026

20,353 people reported to have side effects when taking Bumetanide.
Among them, 35 people (0.17%) have Tumor.

Among these 35 people:

What is the gender of people who have Tumor when taking Bumetanide? *

female: 91.43 %
male: 8.57 %

What is the age of people who have Tumor when taking Bumetanide? *

What are other drugs people take besides Bumetanide? *

What are other side effects people have besides Tumor? *

Sinusitis (inflammation of sinus): 26 people, 74.29%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 24 people, 68.57%
Cardiac Failure Congestive: 24 people, 68.57%
Anaemia (lack of blood): 19 people, 54.29%
Injury: 19 people, 54.29%
Weakness: 18 people, 51.43%
Pain In Jaw: 18 people, 51.43%
Pain: 18 people, 51.43%
Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 18 people, 51.43%
Stress And Anxiety: 18 people, 51.43%

What are the existing conditions these people have? *

Pain: 21 people, 60.00%
Metastases To Bone (cancer spreads to bone): 17 people, 48.57%
Neuralgia (pain in one or more nerves): 4 people, 11.43%
Rashes (redness): 3 people, 8.57%
Barrett's Oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach): 3 people, 8.57%
Complex Regional Pain Syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet)): 3 people, 8.57%
Skin Irritation: 3 people, 8.57%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 8.57%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 5.71%
Depression: 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Bumetanide and have Tumor?

- Check whether Tumor is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bumetanide:

Bumetanide (20,532 reports)

Tumor treatments and more:

Tumor (38,734 reports)

Browse all side effects of Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tumor:

Tumor (1,419 drugs)

Browse all the conditions that are associated with Tumor:

Tumor (1,704 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bumetanide (the active ingredients of Bumetanide) and Bumetanide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.